Celgene Corp (CELG) 120.43 $CELG Midday Glance:

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Celgene Corp (CELG) 120.43 $CELG

Midday Glance: Biotechnology companies
AP - 17 mins ago
NEW YORK (AP) — Shares of some top biotechnology companies are up at 1 p.m.:
GILD: 100.97 (+1.36), AMGN: 162.13 (+7.87), CELG: 120.43 (+2.70)

Early Glance: Biotechnology companies
AP - Mon Mar 16, 9:34AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are up at 10 a.m.:
GILD: 100.97 (+1.36), AMGN: 162.13 (+7.87), CELG: 120.43 (+2.70)

3 Biotech Stocks Wall Street Loves
Keith Speights, The Motley Fool - Motley Fool - Mon Mar 16, 7:01AM CDT
Source: Wikimedia Commons . How can you know when Wall Street really loves a stock? One key sign is how many of the analysts covering the stock maintain buy ratings. Another tell-tale indicator is the price targets these analysts give for the...
GILD: 100.97 (+1.36), ALXN: 179.05 (+2.16), CELG: 120.43 (+2.70)

Should Gilead Sciences Inc.’s Slowing Growth Concern Investors?
George Budwell, The Motley Fool - Motley Fool - Sun Mar 15, 7:57AM CDT
The failure of the market to buy into Gilead Sciences ' amazing growth story is a flat-out mystery in the eyes of many investors. Despite growing product sales by an astounding 127% and non-GAAP earnings per share by 297% last year, the stock has...
BIIB: 420.50 (+7.15), ESRX: 83.52 (+2.15), GILD: 100.97 (+1.36), AMGN: 162.13 (+7.87), ABBV: 58.88 (+0.88), CELG: 120.43 (+2.70)

The Average American Spends This Much On Healthcare Every Year -- Do You?
Todd Campbell, The Motley Fool - Motley Fool - Sun Mar 15, 7:03AM CDT
Source: Flickr user 401kcalculator.org According to the annual healthcare spending report that is put together by the Centers for Medicare and Medicaid Services, Americans spend $3 trillion (yes, with a T) on healthcare every year. That spending is...
HCA: 72.97 (+1.17), ANTM: 153.28 (+3.27), UNH: 117.65 (+2.40), CYH: 50.36 (+0.13), CELG: 120.43 (+2.70)

Celgene, Kinder Morgan and Actavis Set to Join the S&P 100; Several Constituent Changes Announced for S&P 500, S&P MidCap 400 and S&P SmallCap 600
PR Newswire - Fri Mar 13, 4:50PM CDT
S&P Dow Jones Indices will make the following changes to the S&P 100, S&P 500, S&P MidCap 400 and S&P SmallCap 600 indices:
KMI: 40.48 (+0.56), BDX: 143.88 (+2.03), AVP: 7.30 (-0.42), ACT: 304.09 (+5.14), TLMR: 15.38 (+0.56), NBR: 11.62 (-0.34), FCX: 17.65 (-0.49), SLG: 128.78 (+1.36), MHFI: 105.83 (+1.54), BWLD: 189.42 (+4.85), CELG: 120.43 (+2.70), NOV: 48.16 (-0.91), EQIX: 237.10 (+6.61), CFN: 60.13 (+0.16), APA: 59.12 (-0.24), HBI: 33.65 (+1.04), DNR: 7.12 (-0.19), HSIC: 139.82 (+3.45), CELGZ: 3.02 (-0.03)

Final Glance: Biotechnology companies
AP - Thu Mar 12, 5:04PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies were mixed at the close of trading:
GILD: 100.97 (+1.36), AMGN: 162.13 (+7.87), CELG: 120.43 (+2.70)

How to Trade 5 Big Stocks for Big Gains: Must-See Charts
at The Street - Thu Mar 12, 11:06AM CDT
Here's how to trade some of the biggest stocks on Wall Street.
F: 16.40 (+0.20), IBM: 155.95 (+1.67), UNH: 117.65 (+2.40), WFC: 55.61 (+0.27), CELG: 120.43 (+2.70)

Will Biogen Drug Score Big At Alzheimer's Conference?
at Investor's Business Daily - Wed Mar 11, 8:52AM CDT
A new research note from RBC Capital Markets offers a bullish take on Biogen Idec's (BIIB) experimental drug for Alzheimer's disease, predicting it will make a big splash at the upcoming International Conference on Alzheimer's and Parkinson's...
JNJ: 100.64 (+1.43), BIIB: 420.50 (+7.15), GILD: 100.97 (+1.36), PFE: 34.44 (+0.44), AMGN: 162.13 (+7.87), LLY: 71.10 (+1.21), CELG: 120.43 (+2.70)

Cellectis: Finding Value In A Crowded CAR-T Space
Bay Area Biotech - at Seeking Alpha - Tue Mar 10, 8:51PM CDT
Chimeric Antigen Receptor (CAR)-engineered T-cells are an exciting, emerging new space in cancer therapy. At recent American Society of Hematology (ASH) annual meetings, the CAR presentations were met with the most fanfare, attention,...
BLUE: 122.98 (+3.05), ZIOP: 13.10 (-0.22), PFE: 34.44 (+0.44), XON: 45.69 (-0.80), AMGN: 162.13 (+7.87), GSK: 46.94 (+0.57), IMUC: 0.56 (-0.01), CELG: 120.43 (+2.70), JNJ: 100.64 (+1.43), BLCM: 24.60 (+1.77), KITE: 63.10 (+0.01), JUNO: 52.62 (+3.13), NVS: 97.98 (+0.94)

3 Stocks to Buy Following Earnings Season
Matthew Frankel, Dan Caplinger, and Todd Campbell, The Motley Fool - Motley Fool - Tue Mar 10, 5:29AM CDT
With earnings season in the books, we've seen a lot of surprises, some good and some bad. We asked three of our analysts for the best stocks to buy now that earnings season is behind us. Here's what they had to say: Dan Caplinger: One of the...
TRIP: 82.70 (+0.18), PG: 83.26 (+1.43), CELG: 120.43 (+2.70)

Biotechnology Boom
Young Money Monsters - at Seeking Alpha - Tue Mar 10, 4:48AM CDT
Editor's note: Originally published on March 6, 2015 by Jacob Urban Biotechnology has been the topic of many investment conversations of late, and as of now there might not be a hotter sector. Despite the rise in biotechnology over the past...
BBP: 31.84 (+0.27), PBE: 57.00 (+0.83), BIIB: 420.50 (+7.15), SBIO: 30.68 (+0.27), BBC: 33.77 (+0.32), GILD: 100.93 (+1.32), FBT: 123.39 (+2.52), XBI: 230.56 (+2.13), BBH: 133.25 (+2.94), AMGN: 162.13 (+7.87), CELG: 120.43 (+2.70)

Oncology Biotech Company Could Be on the Cusp of New PRP Drug for the Treatment and Prevention of Metastatic Cancer
ACCESSWIRE - Mon Mar 09, 9:37AM CDT
WINDSOR, ON / ACCESSWIRE / March 9, 2015 / The Wealthy Biotech Trader, an Investment Newsletter focused on showing everyday Investors new opportunities in rapidly growing, little-known Biotech stocks, would like to announce some recent breakthroughs in the development of new cancer treatments, and the companies that play in the field.
BLUE: 122.98 (+3.05), BIIB: 420.50 (+7.15), GILD: 100.93 (+1.32), KITE: 63.10 (+0.01), ARIA: 8.67 (+0.19), CELG: 120.43 (+2.70)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

AI Deception Challenges the Confidence of Fraud Defenses

Updated Category News Views 138

Fraud Week Spotlights AI Deception Alright, here's the rub: we're in Fraud Week 2026, and boy, is AI shaking the foundations of yesterday's fraud defenses! With all this AI talk, you would expect systems to be near invincible by now. But reality? A different beast altogether. AI has this knack of tripling up the complexity while pretending to solve it, making traditional...

Continue Reading
Mitsubishi CEO Chikumoto Wins 2026 Palladium Medal

Updated Category News Views 147

Here's something to tip your hat to: Manabu Chikumoto, the head honcho of Mitsubishi Chemical Group, snagged the 2026 International Palladium Medal. You don't get this one by just sitting pretty behind a desk. The folks at the Société de Chimie Industrielle—the ones responsible for this prestigious accolade—know a thing or two about setting high bars in the chemical...

Continue Reading
Business Boom in 2026: Key Regions to Watch Now

Updated Category News Views 167

Business Formations Break Records in 2026 I'm telling you, the entrepreneurial spirit is alive and kicking across the States this year. The latest numbers from Registered Agents Inc are clear as day: business is bustling. We're looking at 576,818 new business setups nationwide just in October 2026. That's outpacing the previous year by a whopping 8%. And if that doesn't...

Continue Reading
Morgan County, IN: An Oasis for Balanced Living

Updated Category News Views 94

Why Morgan County? A Question for Homebuyers Ever wondered what makes Morgan County, IN, such a hot ticket for folks looking to escape the daily grind of big city life? Rachel Blacklidge, real estate wizard and hometown hero, lays it all out in a way even the most city-bound among us can appreciate. Small-Town Vibes, Big-City Access Let’s face it—sometimes the chaos...

Continue Reading
Accuray Finishes Key Deal, Resetting Financial Trajectory

Updated Category News Views 112

Accuray Secures the Deal, But Is the Future Bright? Every now and then in the investing world, a company pulls off a maneuver that you wish you’d thought of first. Today, folks, it's Accuray's turn. They've just wrapped up a monstrous transaction with TCW – their primary lender and shareholder – that has them feeling optimistic about the road ahead. Bold Moves to...

Continue Reading
TagMaster To Acquire Kapsch's RFID Ops in NA Market

Updated Category News Views 124

A Strategic Move in the Transportation Sector Here's a fresh shake-up for the North American transportation sector: TagMaster, alongside its U.S. subsidiary Sensys Networks, is all set to acquire Kapsch TrafficCom's RFID-focused North American components business. This isn't just a minor shuffle—this deal could ripple through the industry, promising strategic uplifts...

Continue Reading
PangeAI and Sky Blue Transform Data Center Decisions

Updated Category News Views 80

Just when you thought the incessant trials of picking a prime data center site couldn’t get any more grueling or expensive, enter PangeAI and its brand-new ally, Sky Blue Impact. These tech firms have partnered up to speed up what has traditionally been a sluggish, pricey process. Here’s the deal: PangeAI’s geospatial AI platform lets Sky Blue dodge the usually...

Continue Reading
Betterness Expands Health Networks with $3.5M Boost

Updated Category News Views 60

Defining a Health Revolution in the Heart of Miami Just when you think the fitness tech scene might be settling into its groove, along comes Betterness, Inc., shaking things up with another cool million in their pockets. I'm talking about their recent addition to their seed round, now sitting pretty at a robust $3.5 million. You can't ignore how they're taking a...

Continue Reading
Later's NYC Summit Reinvents Social Commerce Game Plan

Updated Category News Views 120

Creators and Corporates Collide Imagine this: an NYC stage not adorned with Broadway's finest, but with digital maestros steering a new age in social commerce. That's what Later is betting on with their Creator Live summit, debuting in the bustling heart of New York City. We're talking about influencers not just as Instagram stars, but as key players in a $480 billion...

Continue Reading
KeyCorp Plans Redemption of Series E Preferred Stock

Updated Category News Views 99

KeyCorp Drops a Major Redemption Bombshell Out of the blue, KeyCorp (NYSE: KEY) just tossed a curveball at investors with the announcement they’re redeeming every last one of their Series E Fixed-to-Floating Rate Perpetual Non-Cumulative Preferred Stock shares come December 15, 2026. This move is bound to stir the pot a bit even if you’ve been around the block a few...

Continue Reading

Top 5 Most Recently Viewed Articles

Trump Media Stock Soars Amid His Commitment to Ownership

Updated Category News Views 115

Trump Media Stock Soars as Trump Affirms Commitment to Ownership Shares of Trump Media and Technology had a notable surge recently after Donald Trump reiterated his dedication to keeping his majority stake in the company, which oversees Truth Social. During a press briefing at a golf club, Trump firmly stated, “I have absolutely no intention of selling,” which sparked...

Continue Reading
Gentherm Unveils 2024 Sustainability Initiatives and Progress

Updated Category News Views 333

Gentherm's Focus on Longevity and Sustainability Gentherm, a prominent player in innovative thermal management, has recently unveiled its impressive 2024 Sustainability Report. This report sheds light on the vital aspects that define Gentherm's mission: prioritizing people, preserving our planet, and enhancing product offerings. Commitment to a Greener Tomorrow According...

Continue Reading
Biomea Fusion Moves Forward with New Securities Offering

Updated Category News Views 208

Biomea Fusion Announces Public Offering of Securities Biomea Fusion, Inc. (Nasdaq: BMEA), a prominent clinical-stage company tackling diabetes and obesity, has officially started an underwritten public offering. This offering includes shares of its common stock paired with warrants that enable the purchase of additional shares. Alternatively, certain investors may opt for...

Continue Reading
Air Lease Corporation Launches $2 Billion Commercial Paper Initiative

Updated Category News Views 117

Air Lease Corporation Unveils New Commercial Paper Program Air Lease Corporation (NYSE: AL) has taken a significant step forward by establishing a robust commercial paper program with a total value of $2.0 billion. This initiative marks a strategic move designed to enhance the Company's financial flexibility and to support its ongoing operational needs. Understanding the...

Continue Reading
FTI Consulting Welcomes Banking Specialist Christopher Allen

Updated Category News Views 280

FTI Consulting Welcomes Banking Specialist Christopher Allen FTI Consulting, Inc. (NYSE: FCN) is excited to announce that banking and payments expert Christopher Allen has joined the firm as a Senior Managing Director in the Financial Services practice. This timely appointment comes amid significant transformations in the financial services landscape as organizations...

Continue Reading